scholarly article | Q13442814 |
P50 | author | Ashlee V Moses | Q95982764 |
P2093 | author name string | Timothy M Rose | |
David Wu | |||
Serge Barcy | |||
Gail H Deutsch | |||
H Jacques Garrigues | |||
Keiji Ueda | |||
Kellie Howard | |||
Minako Ikoma | |||
P2860 | cites work | Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts. | Q42833621 |
Microsequencing of proteins electrotransferred onto immobilizing matrices from polyacrylamide gel electrophoresis: application to an insoluble protein | Q43618989 | ||
Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study | Q44210720 | ||
A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. | Q44913048 | ||
Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation | Q46167434 | ||
Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size | Q47231411 | ||
Regulation of nuclear import by phosphorylation adjacent to nuclear localization signals | Q48004807 | ||
Lymph Nodes Involved by Multicentric Castleman Disease Among HIV-positive Individuals are Often Involved by Kaposi Sarcoma | Q59621846 | ||
Expression of human herpesvirus-8 (HHV-8) encoded pathogenic genes in Kaposi's Sarcoma (KS) primary lesions | Q59647836 | ||
Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease | Q61776908 | ||
Differential detergent fractionation of isolated hepatocytes: biochemical, immunochemical and two-dimensional gel electrophoresis characterization of cytoskeletal and noncytoskeletal compartments | Q72048900 | ||
Changes in keratin gene expression during terminal differentiation of the keratinocyte | Q72609330 | ||
Morphogenesis of HHV8 in primary human dermal microvascular endothelium and primary effusion lymphomas | Q73172582 | ||
The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells | Q73184792 | ||
Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease | Q73642658 | ||
Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
The lytic activation of KSHV during keratinocyte differentiation is dependent upon a suprabasal position, the loss of integrin engagement, and calcium, but not the interaction of cadherins | Q82486710 | ||
Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays | Q83142880 | ||
Differential Detergent Fractionation of Eukaryotic Cells | Q83506633 | ||
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate | Q24301376 | ||
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway | Q24306635 | ||
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells | Q24527215 | ||
Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. | Q24531182 | ||
Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus | Q24561400 | ||
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen | Q24672438 | ||
CRM1 is an export receptor for leucine-rich nuclear export signals | Q27860453 | ||
Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA | Q28118718 | ||
KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA | Q28474913 | ||
Oncogenic herpesvirus KSHV Hijacks BMP-Smad1-Id signaling to promote tumorigenesis | Q28540651 | ||
LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex | Q28540872 | ||
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation | Q30535717 | ||
Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome | Q30668836 | ||
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus | Q33559699 | ||
Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency | Q33632932 | ||
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus | Q33784966 | ||
Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8 | Q33814510 | ||
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. | Q33817882 | ||
Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene | Q33824419 | ||
Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. | Q33836726 | ||
Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency | Q33843211 | ||
Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes | Q33851443 | ||
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
Conservation of Complex Nuclear Localization Signals Utilizing Classical and Non-Classical Nuclear Import Pathways in LANA Homologs of KSHV and RFHV | Q33895240 | ||
Cell size correlates with phenotype and proliferative capacity in human corneal epithelial cells | Q34004236 | ||
Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication | Q34128791 | ||
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 | ||
Calcium regulation of growth and differentiation of mouse epidermal cells in culture | Q34248695 | ||
Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication | Q34261905 | ||
Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential | Q34353280 | ||
The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma | Q34391203 | ||
Phosphorylation of the chromatin binding domain of KSHV LANA | Q34456086 | ||
cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection | Q34469746 | ||
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection | Q34648384 | ||
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells | Q34997083 | ||
The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection | Q35077558 | ||
Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 | ||
Five-parameter fluorescence imaging: wound healing of living Swiss 3T3 cells | Q35085825 | ||
Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses | Q35720026 | ||
Post-Translational Modifications of Kaposi’s Sarcoma-Associated Herpesvirus Regulatory Proteins – SUMO and KSHV | Q35755464 | ||
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease | Q35764989 | ||
Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen | Q35774091 | ||
High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma | Q35787282 | ||
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. | Q35809792 | ||
MAP kinases and cell migration | Q35889220 | ||
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc | Q36099076 | ||
Involucrin synthesis is correlated with cell size in human epidermal cultures | Q36205249 | ||
Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro | Q36221429 | ||
Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways | Q36454456 | ||
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 | ||
Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS | Q36646579 | ||
Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. | Q36911800 | ||
Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt | Q36978654 | ||
Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin | Q37010247 | ||
Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program | Q37060535 | ||
The ORF59 DNA polymerase processivity factor homologs of Old World primate RV2 rhadinoviruses are highly conserved nuclear antigens expressed in differentiated epithelium in infected macaques | Q37448524 | ||
A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication | Q37523519 | ||
Cell size as a determinant of the clone-forming ability of human keratinocytes | Q37528349 | ||
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
KSHV cell attachment sites revealed by ultra sensitive tyramide signal amplification (TSA) localize to membrane microdomains that are up-regulated on mitotic cells | Q37638617 | ||
Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells | Q37727998 | ||
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis | Q38597909 | ||
Consequences of exposure to initiating levels of carcinogens in vitro and in vivo: altered differentiation and growth, mutations, and transformation | Q38663082 | ||
Expression of the Peptide Antibiotic Human β-Defensin 1 in Cultured Gingival Epithelial Cells and Gingival Tissue | Q39572822 | ||
Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells | Q39580911 | ||
Cloning and Functional Analysis of Kaposi’s Sarcoma-Associated Herpesvirus DNA Polymerase and Its Processivity Factor | Q39582755 | ||
Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 | ||
DNA-PK/Ku complex binds to latency-associated nuclear antigen and negatively regulates Kaposi's sarcoma-associated herpesvirus latent replication. | Q39725564 | ||
De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells | Q39748116 | ||
Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells | Q39752549 | ||
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation | Q39852047 | ||
The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions | Q39877021 | ||
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. | Q39960021 | ||
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. | Q39992257 | ||
Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells | Q39996542 | ||
AGS and other tissue culture cells can unknowingly be persistently infected with PIV5; a virus that blocks interferon signalling by degrading STAT1. | Q40131626 | ||
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen | Q40169138 | ||
KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity | Q40286016 | ||
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 | ||
Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
The restricted cellular host range of human herpesvirus 8. | Q40868542 | ||
Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. | Q40923894 | ||
Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line | Q40959840 | ||
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 | ||
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains | Q41860564 | ||
The induction of epidermal transglutaminase and terminal differentiation by tumor promoters in cultured epidermal cells | Q42242068 | ||
Association of p63 with proliferative potential in normal and neoplastic human keratinocytes | Q42481013 | ||
Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation | Q42584376 | ||
Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies | Q42665921 | ||
Identification and Characterization of Human Herpesvirus-8 Lytic Cycle-Associated ORF 59 Protein and the Encoding cDNA by Monoclonal Antibody | Q42671697 | ||
Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells | Q42710003 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytoplasm | Q79899 |
P577 | publication date | 2017-11-30 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication | |
P478 | volume | 91 |